Clinical trial
Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma
NCT02977702 is registered in ClinicalTrials.gov with Institut de Cancérologie de Lorraine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma
- Lead sponsor
- Institut de Cancérologie de Lorraine
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- May 31, 2016
- Enrollment
- 114 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.